Willard H Dere's Net Worth
$3.56 Million
Who is Willard H Dere?
Willard H Dere has an estimated net worth of $3.56 Million. This is based on reported shares across multiple companies, which include AMGEN INC, Mersana Therapeutics, Inc., BIOMARIN PHARMACEUTICAL INC, Seres Therapeutics, Inc., Radius Health, Inc., Ocera Therapeutics, Inc., and Metagenomi, Inc..
SEC CIK
Willard H Dere's CIK is 0001311569
Past Insider Trading and Trends
2016 was Willard H Dere's most active year for acquiring shares with 7 total transactions. Willard H Dere's most active month to acquire stocks was the month of May. 2022 was Willard H Dere's most active year for disposing of shares, totalling 3 transactions. Willard H Dere's most active month to dispose stocks was the month of July. 2022 saw Willard H Dere paying a total of $99,999.90 for 145,073 shares, this is the most they've acquired in one year. In 2020 Willard H Dere cashed out on 6,355 shares for a total of $582,146.05, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMGEN INC (AMGN) Snapshot price: $320.56
Sr. V.P., Global Dev & CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mersana Therapeutics, Inc. (MRSN) Snapshot price: $1.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
| +18.48% | 6.11K |
—
|
—
| 39.18K |
Jan 2
| |||
Form 4
| +49.92% | 11.01K |
—
|
—
| 33.07K |
Oct 2
| |||
Form 4
| +23.64% | 4.22K |
—
|
—
| 22.06K |
Jul 3
| |||
Form 4
| +428.65% | 14.47K |
—
|
—
| 17.84K |
Jun 8
| |||
Form 4
|
∞
| 3.38K |
—
|
—
| 3.38K |
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +17.11% | 4.72K |
—
|
—
| 32.3K |
May 21
| |||
Form 4
| +17.91% | 4.19K |
—
|
—
| 27.58K |
May 23
| |||
Form 4
| +27.05% | 4.98K |
—
|
—
| 23.39K |
May 24
| |||
Form 4
| +38.53% | 5.12K |
—
|
—
| 18.41K |
May 25
| |||
Form 4
| -25.00% | -4.43K |
$123.61 | -$547,592.30 | 13.29K |
Scheduled
|
Jun 26
| ||
Form 4
| +32.04% | 4.3K |
—
|
—
| 17.72K |
May 27
| |||
Form 4
| +49.28% | 4.43K |
—
|
—
| 13.42K |
Jun 4
| |||
Form 4
| +91.68% | 4.3K |
—
|
—
| 8.99K |
Jun 5
| |||
Form 4
| +77.65% | 2.05K |
—
|
—
| 4.69K |
Jun 6
| |||
Form 4/A
|
∞
| 2.64K |
—
|
—
| 2.64K |
Jul 15
| |||
Form 4
|
∞
| 3.3K |
—
|
—
| 3.3K |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 31.75K |
$3.15 | $99,999.90 | 31.75K |
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Radius Health, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -23.20K |
$10.00 | -$231,950.00 |
0
|
Aug 15
| |||
Form 4
| +31.08% | 5.5K |
—
|
—
| 23.2K |
Jan 14
| |||
Form 4
| +45.10% | 5.5K |
—
|
—
| 17.7K |
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
| -13.63% | -1.93K |
$17.95 | -$34,553.75 | 12.2K |
Scheduled
|
Feb 26
| ||
Form 4
| +63.81% | 5.5K |
—
|
—
| 14.12K |
Feb 20
| |||
Form 4
| -16.31% | -1.68K |
$22.22 | -$37,329.60 | 8.62K |
Scheduled
|
Apr 16
| ||
Form 4
| +114.58% | 5.5K |
—
|
—
| 10.3K |
Feb 22
| |||
Form 4
|
∞
| 4.8K |
—
|
—
| 4.8K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |